Evidence map›Paper›PMID 30926729›Full record

ArticleApplied and environmental microbiology2019

Development of a CRISPR/Cas9 System for Methylococcus capsulatus

Timothy Tapscott, Michael T Guarnieri, Calvin A Henard

Open access · hybridAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Optimized Tools and Methods for Methanotroph Genome Editing.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Timothy Tapscott *National Bioenergy Center, National Renewable Energy Laboratory (NREL), Golden, Colorado, USA.
Michael T GuarnieriNational Bioenergy Center, National Renewable Energy Laboratory (NREL), Golden, Colorado, USA Michael.guarnieri@nrel.gov calvin.henard@nrel.gov.
Calvin A Henard *National Bioenergy Center, National Renewable Energy Laboratory (NREL), Golden, Colorado, USA Michael.guarnieri@nrel.gov calvin.henard@nrel.gov.ORCID 0000-0002-4574-587X
National Laboratory of the Rockies · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methanotrophic bacteria play a crucial role in the Earth's biogeochemical cycle and have the potential to be employed in industrial biomanufacturing processes due to their capacity to use natural gas- and biogas-derived methane as a sole carbon and energy source. Advanced gene-editing systems have the potential to enable rapid, high-throughput methanotrophic genetics and biocatalyst development. To this end, we employed a series of broad-host-range expression plasmids to construct a conjugatable

Indexed as

CRISPR-Cas SystemsBacterial ProteinsClustered Regularly Interspaced Short Palindromic RepeatsCodon, TerminatorCRISPR-Associated Protein 9Deoxyribonuclease IGene EditingGene Expression Regulation, BacterialGenome, BacterialMethylococcus capsulatusOxygenasesPlasmidsBacterial ProteinsCas9 endonuclease Streptococcus pyogenesCodon, TerminatorCRISPR-Associated Protein 9Deoxyribonuclease Imethane monooxygenaseOxygenasesCRISPR/Cas9gene editingmethane biocatalystmethane monooxygenasemethanotrophMethylococcus capsulatus

Identifiers

PMID30926729
PMCPMC6532038
OpenAlexW2923084181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.